- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Monkeypox: 7 Questions Patients May Ask, Answers to Help Prepare
The ongoing spread of monkeypox was declared a public health emergency in the US on Thursday, August 4, 2022, as national cases topped 7100. Despite the rising number of confirmed cases, and the global spotlight on the monkeypox outbreak, many questions linger about this rare disease: What exactly is monkeypox? What are the symptoms? How does it spread? Is it a sexually transmitted infection?
Patients may ask these questions, and others, at their next clinical visit. To help primary care clinicians respond, the editors at Patient Care Online combed through the US Centers for Disease Control and Prevention's list of frequently asked questions about monkeypox and selected 7 you are likely to hear. Scroll the slides below for details.
FDA Approves First Oral GLP-1 Receptor Agonist for Chronic Weight Management
December 23rd 2025The FDA approved once-daily oral semaglutide 25 mg for chronic weight management and long-term weight maintenance in adults with obesity or overweight, based on data from the OASIS clinical trial program.
Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss
December 19th 2025Topline Phase 3 ATTAIN-MAINTAIN data show oral orforglipron met primary and key secondary endpoints for weight maintenance after prior GLP-1–based injectable therapy in adults with obesity.
